Endure Industries, Inc.

CourtArmed Services Board of Contract Appeals
DecidedMarch 23, 2026
Docket64064
StatusPublished

This text of Endure Industries, Inc. (Endure Industries, Inc.) is published on Counsel Stack Legal Research, covering Armed Services Board of Contract Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Endure Industries, Inc., (asbca 2026).

Opinion

ARMED SERVICES BOARD OF CONTRACT APPEALS

Appeal of - ) ) Endure Industries, Inc. ) ASBCA No. 64064 ) Under Contract No. SP0200-22-H-0049 )

APPEARANCE FOR THE APPELLANT: Mr. Manoj Kumar

APPEARANCES FOR THE GOVERNMENT: Song U. Kim, Esq. Associate General Counsel Weston E. Borkenhagen, Esq. Trial Attorney Defense Health Agency Falls Church, VA

OPINION BY ADMINISTRATIVE JUDGE HERZFELD ON THE GOVERNMENT’S MOTION TO DISMISS

Endure Industries, Inc. (Endure), appeals the Defense Health Agency’s (DHA’s) decision to cancel Endure’s incentive agreement to provide sterilization packaging supplies. DHA moves to dismiss Endure’s complaint, asserting that Endure’s incentive agreement was not a contract with the government and, thus, Endure has failed to state a claim upon which relief may be granted. In its response to the motion, Endure asserts for the first time that it also has a separate implied-in-fact contract with the government. For the reasons discussed below, we dismiss Endure’s appeal.

STATEMENT OF FACTS FOR PURPOSES OF THE MOTION

The Defense Logistics Agency’s Troop Support (DLA Troop Support) is the Department of Defense’s (DoD) contracting office responsible for supplying pharmaceuticals, surgical supplies, and medical equipment to DoD’s worldwide medical treatment facilities. DEFENSE LOGISTICS AGENCY, Working with DLA Troop Support Medical, https://www.dla.mil/Troop-Support/Medical/Working-with- Medical/#mpvp (last visited Mar. 19, 2025). DLA Troop Support contracts with pharmaceutical and medical/surgical distributers – “prime vendors” – that can deliver, within 24-hours, supplies ordered by DoD’s military treatment facilities at prices authorized by DLA Troop Support. Id. DLA Troop Support separately enters distribution and pricing agreements with manufacturers and suppliers of pharmaceutical and medical/surgical products. Id. The distribution and pricing agreement provides “fair and reasonable” prices for these products, which the prime vendors may rely on to purchase and distribute the products to military treatment facilities. Id.

Endure produces and supplies disposable medical products, including sterilization packaging supplies such as the peel packs for steam sterilization (at issue in this appeal) (compl. ¶¶ 1, 3). Endure registered for a distribution and pricing agreement on DLA Troop Support’s website (R4, tab 7). DLA Troop Support approved the agreement on September 21, 2022, which the website lists as the “Contract” effective date under the “Contract Details” part of the website (id. at 1). As part of the distribution and pricing agreement, Endure agreed to the terms and conditions provided by DLA Troop Support (id. at 2; R4, tab 6). Notwithstanding the terminology on the website, the terms and conditions stated: “The government gives no guarantee that any quantities will be purchased by either Medical Supply Chain or its [Prime Vendor] awardee(s)” and the “issuance of a [distribution and pricing agreement] in no way binds the Government or its awardee(s) to purchase any of the products listed” (R4, tab 6 at 6).

As part of its distribution and pricing agreement with DLA Troop Support, Endure consented and authorized prime vendors (who, as noted above, hold separate contracts with the government) to distribute Endure’s products (R4, tab 6 at 2). The terms and conditions warned that “[i]n order to sell products to the Government under the Prime Vendor Program it is essential that [distribution and pricing agreement] holders enter into a distribution agreement with the Prime Vendor” (R4, tab 6 at 3). The distribution agreement between prime vendor and Endure would separately “outline the terms and conditions by which the Prime Vendor is authorized to store, distribute and/or sell” Endure’s products (id.). Those terms and conditions “shall be consistent with the Prime Vendor’s good, commercial (that is, acceptable industry- standard) business practices” and the “Prime Vendor is not required to accept” an “agreement which appears inconsistent with good, commercial business practices” (id.). As to commercial specifications, the distribution and pricing agreement between Endure and DLA Troop Support stated, “Packaging, packing and marking shall be in conformance with all applicable laws and regulations” (id.).

In February 2023, Endure applied to the Defense Health Agency’s Medical Materiel Enterprise Standardization Offices (DHA) for inclusion on the agency’s qualified supplier list for sterilization packaging supplies (compl. ¶ 4; app. resp., app’x at 16-20). The distribution and pricing agreement’s terms and conditions specifically identify this program, explaining that DHA selects the “vendor offering the best prices . . . to supply the enterprise-wide standardized product line” and the “winning vendor is issued an Incentive Agreement . . . wherein the vendor agrees to provide the standardized products at discounted prices” (R4, tab 6 at 8). The “vendor” here is the supplier (Endure) because suppliers enter incentive agreements, not the “prime vendor” that buys and distributes the qualified products and enters another type of agreement (R4, tab 6 at 7-8; DEFENSE LOGISTICS AGENCY, Working with DLA 2 Troop Support Medical, https://www.dla.mil/Troop-Support/Medical/Working-with- Medical/#mpvp (last visited Mar. 19, 2025).

Based on Endure’s competitive pricing and complying with DHA’s technical specifications, DHA entered an incentive agreement with Endure on May 15, 2023 (R4, tab 1; compl. ¶ 6; app. resp., app’x at 23 (“You are the lowest priced vendor of those on the Qualified Suppliers List (QSL) for the Sterilization Packaging Supplies, Peel Pack, Steam.”). The incentive agreement stated it was “pursuant to” Endure’s distribution and pricing agreement with DLA Troop Support and “incorporated by reference” those terms and conditions (R4, tab 1 at 1). The incentive agreement had a five-year term with “estimated effective dates from 01 November 2023 through 31 October 2028” (R4, tab 1 at 2; compl. ¶ 8). Consistent with the distribution and pricing agreement’s statement that Endure would supply its product enterprise-wide, the incentive agreement stated, “Each facility agrees to purchase the listed products according to the terms outlined in this agreement” (R4, tab 1 at 1).

In the incentive agreement, Endure agreed “that incentive prices are guaranteed firm for 3 years” (R4, tab 1 at 2). Based on the incentive pricing and “good faith volume estimates” provided by Endure in its qualified supplier listing and the incentive agreement “announcements,” DHA stated it would “work[] towards an 80% purchase goal for this product line throughout the life of this agreement” (id.). Although DHA stated it “will advertise and promote [incentive agreement] items, the government has no volume commitment or purchase requirement under this agreement, and it is possible that actual sales may not meet the 80% estimate” (id.). The agreement reiterated: “The 80% estimate does not create a commitment for the government and therefore the vendor should not rely on that estimate” (id.).

As to cancellation, the incentive agreement stated: “This agreement does not represent a contract and may be canceled by either party in whole or in part without cause 30 days after receipt of a written notice” (id. at 3). The incentive agreement also stated: “The parties agree that cancellation of the [incentive agreement] is the only recourse available if the [incentive agreement] holder ceases to be satisfied with the level of sales or any other benefit, tangible or intangible, they expected to receive as an [incentive agreement] holder” (id. at 2).

Endure began manufacturing and stocking its warehouses with the sterilization pouches made to the government’s specific requirements in the incentive agreement (compl. ¶ 11).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell v. Hood
327 U.S. 678 (Supreme Court, 1946)
Burnham v. Superior Court of Cal., County of Marin
495 U.S. 604 (Supreme Court, 1990)
Cooter & Gell v. Hartmarx Corp.
496 U.S. 384 (Supreme Court, 1990)
Seminole Tribe of Florida v. Florida
517 U.S. 44 (Supreme Court, 1996)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Flood v. ClearOne Communications, Inc.
618 F.3d 1110 (Tenth Circuit, 2010)
Zhengxing v. United States
204 F. App'x 885 (Federal Circuit, 2006)
The Franklin Company v. The United States
381 F.2d 416 (Court of Claims, 1967)
The United States v. Johnson Controls, Inc.
713 F.2d 1541 (Federal Circuit, 1983)
Placeway Construction Corporation v. The United States
920 F.2d 903 (Federal Circuit, 1990)
Neal & Company, Inc. v. The United States
945 F.2d 385 (Federal Circuit, 1991)
Trauma Service Group v. United States
104 F.3d 1321 (Federal Circuit, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
Endure Industries, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/endure-industries-inc-asbca-2026.